Completed PHASE1 INTERVENTIONAL 2-arm NCT01756651

Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures

A Prospective Study Comparing the Efficacy and Safety of 100 mcg and 200 mcg of Intranasal Fentanyl Pectin Spray as an Analgesic in Adult Males Undergoing Outpatient Cystoscopic Procedures

Sponsor: Depomed

Conditions Other Acute Pain Pain Experienced During Cystoscopy

Interventions Fentanyl pectin

Updated 8 times since 2017 Last updated: May 10, 2017 Started: Feb 28, 2013 Primary completion: May 10, 2016 Completion: May 10, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Other Acute Pain and Pain Experienced During Cystoscopy, this trial is completed. The trial is conducted by Depomed and has accumulated 8 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Nov 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Nov 2019 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Jun 2017 — Jun 2018 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Feb 2017 — Jun 2017 [monthly]

Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE1

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Depomed
Richard C Reznichek, MD

Data source: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Torrance, United States